Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|April 26, 2017
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinomaRachna T Shroff, Mark Yarchoan, Ashley O'Connor, et al.
Annals of Pancreatic Cancer|April 24, 2018
Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysisAmar B Deshwar, Elizabeth Sugar, Deirdre Torto, et al.
JCI Insight|March 22, 2019
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancersMark Yarchoan, Lee A Albacker, Alexander C Hopkins, et al.
Cancer Immunology Research|May 3, 2019
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable SurvivalLudmila Danilova, Won Jin Ho, Qingfeng Zhu, et al.
Journal for Immunotherapy of Cancer|November 21, 2020
Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapyWon Jin Ho, Gaurav Sharma, Qingfeng Zhu, et al.
JCI Insight|May 22, 2020
Effects of B cell-activating factor on tumor immunityMark Yarchoan, Won Jin Ho, Aditya Mohan, et al.
JCI Insight|July 13, 2018
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinomaAlexander C Hopkins, Mark Yarchoan, Jennifer N Durham, et al.
Cancer Informatics|November 28, 2022
A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 ImmunotherapyEmma Bigelow, Suchi Saria, Brian Piening, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 3, 2010
Who will manage American patients with diabetes? Residents' career preferences and perceptions of diabetes careMark Yarchoan, Michael L Dougan, Melissa Y Tjota, et al.
Abdominal Radiology (New York)|March 28, 2024
Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy: an evaluation of volumetric imaging parametersAlireza Mohseni, Azarakhsh Baghdadi, Seyedeh Panid Madani, et al.
Pageof 14